Smoking Does Not Affect Outcomes of Immunotherapy-Based mRCC Treatments
Unlike some other cancers, smoking status was not predictive in mRCC treated with first-line immunotherapy combinations.
Source: renalandurologynews.com
Stay updated with breaking news from Karnofsky Performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Unlike some other cancers, smoking status was not predictive in mRCC treated with first-line immunotherapy combinations.
The Office of U.S. Representative Young Kim (CA-39) named Diya Sreedhar, Freshman at Troy High School in Fullerton, the winner of the
Around 30% of patients with breast cancer will develop brain metastases (BM). We sought to characterize the disease course, treatments and outcome.